Skip to main content
. 2022 Oct 9;14(19):4950. doi: 10.3390/cancers14194950

Table 1.

Univariate and multivariate COX analysis of OS in NKTL patients.

Variables Hazard Ratio Std. Err. p [95% Conf. Interval]
Gender (male vs. female) 0.752 0.231 0.219 0.478 1.184
Age (<60 vs. ≥60) 1.333 0.262 0.274 0.797 2.229
clinical stage (I–II vs. III–IV) 5.575 0.223 <0.001 * 3.599 8.637
ECOG score (<2 vs. ≥2) 3.960 0.211 <0.001 * 2.618 5.991
circKIF4 (high expression vs. low expression) 0.606 0.208 0.016 * 0.403 0.912
LDH (<60U/L vs ≥60U/L) 2.962 0.210 <0.001 * 1.964 4.466
B symptoms (positive vs. negative) 1.379 0.210 0.122 0.918 2.073
regional lymph nodes invasion (negative vs. positive) 1.962 0.245 0.001 * 1.299 2.964
Multivariate analysis
clinical stage (I–II vs. III–IV) 1.747 0.290 0.055 0.989 3.084
ECOG score (<2 vs. ≥2) 1.166 0.296 0.603 0.654 2.081
circKIF4 (high expression vs. low expression) 0.500 0.223 0.002 * 0.323 0.774
LDH (<60U/L vs ≥60U/L) 0.741 0.232 0.196 0.471 1.167
regional lymph nodes invasion (negative vs. positive) 0.000 52.764 0.803 0.001 1.577

Abbreviations: OS: overall survival; ECOG: eastern cooperative oncology group; LDH: lactate dehydrogenase.* indicates p < 0.05.